Old National Bancorp United Therapeutics Corp Transaction History

Old National Bancorp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 30, 2019	SELL	$107.15 - $126.84 $367,631 - $435,188	-3,431 Closed	0 $0
Q4 2018 Jan 31, 2019	BUY	$101.4 - $128.73 $1,419 - $1,802	14 Added 0.41%	3,431 $374,000
Q3 2018 Oct 26, 2018	SELL	$113.81 - $129.46 $1,934 - $2,200	-17 Reduced 0.5%	3,417 $437,000
Q2 2018 Jul 26, 2018	BUY	$101.14 - $118.31 $347,314 - $406,276	3,434 New	3,434 $389,000

672

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Old National Bancorp , based on Form 13F filings with the SEC.

Stay updated on Old National Bancorp with notifications on news.